Download presentation

1
**Clinical Pharmacokinetics**

Introduction

2
**How to use this powerpoint presentation**

This supplements the other course material You can view it on line or download it to your computer and view it without being connected to the internet. Work through the presentation at the start of the course and note any issue which are not clear. Read up on areas that you are not familiar with and revisit the presentation from time to time. Try the powerpoint based exercises

3
**What is clinical pharmacokinetics ?**

Study of the time course of a drug’s movement through the body. Understanding of what the body does to (or with) the drug. Application of Therapeutic Drug Monitoring (TDM) and individualisation of drug therapy.

4
**Outline Review of Concepts Therapeutic drug Monitoring**

Clearance, K, Half-Life, Volume of Distribution Therapeutic drug Monitoring Pharmacokinetic Drug Interactions Cases Discussion/Questions

5
**Pharmacokinetics (PK) & pharmacodynamics (PD)**

PK - What the body does to the drug? Absorption; distribution, metabolism, excretion (ADME) PD - What the drug does to the body? Drug concentration at the site of action or in the plasma is related to a magnitude of effect

6
**Pharmacokinetics (PK) and pharmacodynamics (PD)**

Plasma Site Concen of tration Action Dose Effects PK PD

7
**Pharmacokinetics vs Pharmacodynamics…concept**

Fluoxetine increases plasma concentrations of amitriptyline. This is a pharmacokinetic drug interaction. Fluoxetine inhibits the metabolism of amitriptyline and increases the plasma concentration of amitriptytline.

8
**Pharmacokinetics vs Pharmacodynamics…concept**

If fluoxetine is given with tramadol serotonin syndrom can result. This is a pharmacodynamic drug interaction. Fluoxetine and tramadol both increase availability of serotonin leading to the possibility of “serotonin overload” This happens without a change in the concentration of either drug.

9
Basic Parameters In the next few slides the basic concepts and paramaters will be described and explained. In pharmacokinetics the body is represented as a single or multiple compartments in to which the drug is distributed. Some of the parameters are therefore a little abstract as we know the body is much more complicated !

10
**Volume of Distribution, Clearance and Elimination Rate Constant**

Volume 100 L Clearance 10 L/hr

11
**Volume of Distribution, Clearance and Elimination Rate Constant**

Volume 100 L (Vi) V2 Cardiac and Skeletal Muscle Clearance 10 L/hr

12
**Volume of Distribution =**

Cardiac and Skeletal Muscle Volume 100 L (Vi) V Clearance 10 L/hr Volume of Distribution = Dose_______ Plasma Concentration

13
**Volume of blood cleared of drug per unit time**

Cardiac and Skeletal Muscle Volume 100 L (Vi) V Clearance 10 L/hr Clearance = Volume of blood cleared of drug per unit time

14
**Volume 100 L (Vi) Clearance = 10 L/hr Volume of Distribution = 100 L**

Cardiac and Skeletal Muscle Volume 100 L (Vi) V Clearance 10 L/hr Clearance = 10 L/hr Volume of Distribution = 100 L What is the Elimination Rate Constant (k) ?

15
CL = kV k = 10 Lhr -1 = 0.1 hr -1 100 L 10 % of the “Volume” is cleared (of drug) per hour k = Fraction of drug in the body removed per hour

16
CL = kV If V increases then k must decrease as CL is constant

17
Important Concepts VD is a theoretical Volume and determines the loading dose Clearance is a constant and determines the maintenance dose CL = kVD CL and VD are independent variables k is a dependent variable

18
**Volume of Distribution**

Apparent volume of distribution is the theoretical volume that would have to be available for drug to disperse in if the concentration everywhere in the body were the same as that in the plasma or serum, the place where drug concentration sampling generally occurs.

19
**Volume of Distribution**

An abstract concept Gives information on HOW the drug is distributed in the body Used to calculate a loading dose

20
Loading Dose Dose = Cp(Target) x VD

21
**Question What Is the is the loading dose required fro drug A if;**

Target concentration is 10 mg/L VD is 0.75 L/kg Patients weight is 75 kg Answer is on the next slide

22
**Answer: Loading Dose of Drug A**

Dose = Target Concentration x VD VD = 0.75 L/kg x 75 kg = L Target Conc. = 10 mg/L Dose = 10 mg/L x L = 565 mg This would probably be rounded to 560 or even 500 mg.

23
Clearance Ability of organs of elimination (e.g. kidney, liver to “clear” drug from the bloodstream Volume of fluid which is completely cleared of drug per unit time Units are in L/hr or L/hr/kg Pharmacokinetic term used in determination of maintenance doses

24
**Maintenance Dose Calculation**

Maintenance Dose = CL x CpSSav CpSSav is the target average steady state drug concentration The units of CL are in L/hr or L/hr/kg Maintenance dose will be in mg/hr so for total daily dose will need multiplying by 24

25
**Question What maintenance dose is required for drug A if;**

Target average SS concentration is 10 mg/L CL of drug A is L/kg/hr Patient weighs 75 kg Answer on next slide.

26
**Answer Maintenance Dose = CL x CpSSav**

CL = L/hr/kg x 75 = L/hr Dose = L/hr x 10 mg/L = mg/hr So will need x 24 mg per day = 270 mg

27
Half-Life and k Half-life is the time taken for the drug concentration to fall to half its original value The elimination rate constant (k) is the fraction of drug in the body which is removed per unit time.

28
**Intravenous Bolus Injection dC/dt œ C = -k.C = -(CL/V).C**

Drug Concentration Time C1 Exponential decay dC/dt C = -k.C C2 Intravenous Bolus Injection Exponential Decay: dC/dt œ C = -k.C = -(CL/V).C Integrating: C(t) = C(0).e-kt

29
**Intravenous Bolus Injection log C(t) = log C(0) - (kt/2.303)**

Log Concn. Time C0 C0/2 t1/2 t1/2 t1/2 Intravenous Bolus Injection Logarithmic Transform: log C(t) = log C(0) - (kt/2.303) Elimination Half-Life: t1/2 = ln 2/k = V/CL Time to eliminate ~ 4 t1/2

30
**Logarithmic transform: Elimination Half-Life:**

Integrating: Cp2 = Cp1.e-kt Logarithmic transform: lnC2= lnC1 - kt logC2 = logC1 - kt/2.303 Elimination Half-Life: t1/2 = ln2/k t1/2 = 0.693/k

31
Steady-State Steady-state occurs after a drug has been given for approximately five elimination half-lives. At steady-state the rate of drug administration equals the rate of elimination and plasma concentration - time curves found after each dose should be approximately superimposable.

32
**Accumulation to Steady State 100 mg given every half-life**

… 200 194 187.5 175 150 100 … 97 100 94 87.5 75 50

34
**What is Steady State (SS) ? Why is it important ?**

Rate in = Rate Out Reached in 4 – 5 half-lives (linear kinetics) Important when interpreting drug concentrations in TDM or assessing clinical response

35
**Therapeutic Drug Monitoring**

Some Principles

36
**Therapeutic Index Therapeutic index = toxic dose/effective dose**

This is a measure of a drug’s safety A large number = a wide margin of safety A small number = a small margin of safety

37
**Drug Concentrations May Be Useful When There Is:**

An established relationship between concentration and response or toxicity A sensitive and specific assay An assay that is relatively easy to perform A narrow therapeutic range A need to enhance response/prevent toxicity

38
**Why Measure Drug Concentrations?**

Lack of therapeutic response Toxic effects evident Potential for non-compliance Variability in relationship of dose and concentration Therapeutic/toxic actions not easily quantified by clinical endpoints

39
**Potential for Error When Using TDM**

Assuming patient is at steady-state Assuming patient is actually taking the drug as prescribed Assuming patient is receiving drug as prescribed Not knowing when the drug concentration was measured in relation to dose administration Assuming the patient is static and that changes in condition don’t affect clearance Not considering drug interactions

Similar presentations

Presentation is loading. Please wait....

OK

1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.

1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.

© 2018 SlidePlayer.com Inc.

All rights reserved.

To make this website work, we log user data and share it with processors. To use this website, you must agree to our Privacy Policy, including cookie policy.

Ads by Google